Genomcore
Genomcore is a precision medicine platform provider that implements real-world biomedical information management through its modular, cloud-based Genomcore BIMS platform. The platform consists of core ecosystems including Biomed for secure biomedical data governance with compliance and granular access controls, Genomics for full genomic lifecycle support from pre-analytical requests to post-analytical reporting…
Funding snapshot
About
Genomcore is a precision medicine platform provider that implements real-world biomedical information management through its modular, cloud-based Genomcore BIMS platform. The platform consists of core ecosystems including Biomed for secure biomedical data governance with compliance and granular access controls, Genomics for full genomic lifecycle support from pre-analytical requests to post-analytical reporting including NGS, PCR, arrays, and cytogenetics, and Portals for designing web and mobile apps for patients, clinicians, and researchers. Core technology units include a Unified Multimodal Datastore integrating genomic, clinical, imaging, and sensor data; an App Platform with pre-built tools and AI/ML model deployment capabilities; and FrontDesk for no-code patient portal and mobile app creation. The platform is triple ISO-certified and supports GDPR, HIPAA, MDR/IVDR, and ENS compliance. Founded in 2015 and headquartered in Esplugues De Llobregat, Spain, the company has raised $6.3M in Series A funding from investors including Europa, EIC Fund, FC Barcelona, QVIDTVM, Intelectium, and FCV Equity Group.
Business model
Life Sciences Tech > Research & Development > Drug Informatics > Clinical Data Analysis > Omics Analysis,
Genomics > Genome Informatics > Integrative Bioinformatics Platforms,
Life Sciences Platforms and Tools > Research Services > Genomics > Next Generation Sequencing (NGS)
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.